FDA Clearance Tracker · P140003-S107
Impella Ventricular Support Systems
Last checked: Nov 20, 2026Latest source record: Mar 29, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Mar 29, 2023
Approved
Time to decision
166 days
Received Oct 14, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P140003-S107
- Device name
- Impella Ventricular Support Systems
- Applicant
- Abiomed, Inc.
- Applicant location
- Danvers, MA
- Received
- Oct 14, 2022
- Decided
- Mar 29, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P140003
Device type
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for various modifications to the Instructions for Use to add the final results of the Post-Approval Study (PAS) protocol.
Source documents
Other decisions for Abiomed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252766 · Decided Oct 8, 2025 · 40 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.